165 related articles for article (PubMed ID: 15994408)
1. Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertension.
Morice AH; Mulrennan S; Clark A
Eur Respir J; 2005 Jul; 26(1):180; author reply 180-1. PubMed ID: 15994408
[No Abstract] [Full Text] [Related]
2. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil citrate therapy for pulmonary arterial hypertension.
Hoeper MM; Welte T
N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16525151
[No Abstract] [Full Text] [Related]
4. Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy.
Porhownik NR; Al-Sharif H; Bshouty Z
Can Respir J; 2008; 15(8):427-30. PubMed ID: 19107243
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
[TBL] [Abstract][Full Text] [Related]
6. [Bosentan and chronic thromboembolic pulmonary hypertension].
Tomás C; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
Med Clin (Barc); 2007 Nov; 129(16):639. PubMed ID: 18001681
[No Abstract] [Full Text] [Related]
7. Summary for patients. Sildenafil (Viagra) may help improve control of pulmonary hypertension.
Ann Intern Med; 2002 Apr; 136(7):I35. PubMed ID: 11926808
[No Abstract] [Full Text] [Related]
8. Sildenafil for pulmonary arterial hypertension: exciting, but protection required.
Mehta S
Chest; 2003 Apr; 123(4):989-92. PubMed ID: 12684284
[No Abstract] [Full Text] [Related]
9. Combination of sildenafil and bosentan for pulmonary hypertension in a human ex vivo model.
Ried M; Potzger T; Neu R; Sziklavari Z; Szöke T; Liebold A; Hofmann HS; Hoenicka M
Cardiovasc Drugs Ther; 2014 Feb; 28(1):45-51. PubMed ID: 24193244
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre.
Douwes JM; Roofthooft MT; Van Loon RL; Ploegstra MJ; Bartelds B; Hillege HL; Berger RM
Heart; 2014 Feb; 100(3):224-30. PubMed ID: 24390161
[TBL] [Abstract][Full Text] [Related]
12. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
[TBL] [Abstract][Full Text] [Related]
13. Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension.
Paul GA; Gibbs JS; Boobis AR; Abbas A; Wilkins MR
Br J Clin Pharmacol; 2005 Jul; 60(1):107-12. PubMed ID: 15963102
[TBL] [Abstract][Full Text] [Related]
14. Images in congenital heart disease. Reversal of shunting in pulmonary hypertension after treatment with oral Sildenafil.
Karatza AA; Bush A; Magee AG
Cardiol Young; 2002 Dec; 12(6):561-2. PubMed ID: 12636006
[No Abstract] [Full Text] [Related]
15. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
Jue VI
Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
[No Abstract] [Full Text] [Related]
17. Oral Sildenafil in the management of primary pulmonary hypertension.
Malhotra S; Punia VP
J Assoc Physicians India; 2004 Aug; 52():670-2. PubMed ID: 15847367
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit.
Jackson G; Chambers J
Int J Clin Pract; 2002 Jun; 56(5):397-8. PubMed ID: 12137450
[TBL] [Abstract][Full Text] [Related]
19. [Systemic sclerosis: paths into the future].
Guillevin L
Presse Med; 2006 Dec; 35(12 Pt 2):1892-3. PubMed ID: 17159714
[No Abstract] [Full Text] [Related]
20. Treatment of primary pulmonary hypertension with oral sildenafil.
Karatza AA; Narang I; Rosenthal M; Bush A; Magee AG
Respiration; 2004; 71(2):192-4. PubMed ID: 15031578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
